Are we underestimating breast cancer-related lymphedema? The impact of diagnostic thresholds and compression therapy Journal Article


Authors: Wagner, B. D.; Rubin, J.; Boe, L. A.; Diwan, R.; Bloomfield, E.; Giles, C.; Rochlin, D. H.; Yoshimatsu, H.; Mehrara, B. J.; Coriddi, M. R.
Article Title: Are we underestimating breast cancer-related lymphedema? The impact of diagnostic thresholds and compression therapy
Abstract: <p>Background. Breast cancer-related lymphedema (BCRL) is commonly diagnosed using limb volume criteria; however, diagnostic thresholds vary and lack empirical validation. This variability may lead to underdiagnosis, particularly in patients using compression garments that can reduce limb size. Objective. This study evaluated how different diagnostic criteria and compression therapy influence the reported incidence of BCRL. Methods. A single-institution analysis was conducted on 165 female patients with breast cancer originally enrolled in a randomized controlled trial comparing axillary lymph node dissection with and without immediate lymphatic reconstruction from 2020 to 2025. Limb volumes were measured preoperatively and at 12, 18, and 24 months postoperatively. BCRL incidence was assessed using 5%, 10%, and 15% thresholds for relative volume change (RVC) and interlimb volume difference. The Upper Limb Lymphedema-27 (ULL-27) questionnaire evaluated symptoms. Compression use was evaluated to determine the effect on BCRL incidence. Results. BCRL incidence varied by threshold, from 55.8% at 5% RVC to 12.1% at 15% RVC. ULL-27 scores indicated comparable symptom burdens between patients meeting volume-based diagnostic criteria and those wearing compression garments but not meeting volume criteria. Both groups had significantly worse physical domain scores than patients without volume changes or compression use (P < 0.001). Including compression users who did not meet volume criteria increased the incidence of BCRL across all thresholds (e.g., 23.6% to 41.8% at 10% RVC). Conclusions. BCRL incidence varied markedly by volume-based diagnostic thresholds, and inclusion of compression users significantly increased reported rates. Relying solely on volume thresholds may miss symptomatic patients. Integrating compression use and patient-reported outcomes can better identify clinically meaningful BCRL.</p>
Keywords: risk; reconstruction; node dissection; intervention; symptoms; agreement; need; compression garments; breast cancer-related lymphedema; relative volume change; arm-lymphedema; limb volume criteria; diagnostic thresholds; ull-27 questionnaire
Journal Title: Annals of Surgical Oncology
ISSN: 1068-9265
Publisher: Springer  
Publication status: Online ahead of print
Date Published: 2025-09-19
Online Publication Date: 2025-09-19
Language: English
ACCESSION: WOS:001575222300001
DOI: 10.1245/s10434-025-18334-1
PROVIDER: wos
PUBMED: 40968237
Notes: Article; Early Access -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Michelle Coriddi -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Babak Mehrara
    476 Mehrara
  2. Michelle Renee Coriddi
    65 Coriddi
  3. Caitlin Elizabeth Giles
    5 Giles
  4. Danielle Helena Rochlin
    25 Rochlin
  5. Lillian Augusta Boe
    90 Boe
  6. Richard Diwan
    4 Diwan
  7. Jonathan Rubin
    6 Rubin
  8. Benjamin David Wagner
    5 Wagner